Lipoprotein-associated phospholipase A2, vascular inflammation and cardiovascular risk prediction
Krishnankutty SudhirStanford University Medical Center, Stanford, CA, USAAbstract: Circulating lipoprotein-associated phospholipase A2 (Lp-PLA2) is a marker of inflammation that plays a critical role in atherogenesis; its inhibition may have antiatherogenic effects. Studies from the West of Scotland...
Main Author: | Krishnankutty Sudhir |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2006-06-01
|
Series: | Vascular Health and Risk Management |
Online Access: | https://www.dovepress.com/lipoprotein-associated-phospholipase-a2-vascular-inflammation-and-card-peer-reviewed-article-VHRM |
Similar Items
-
Lipoprotein-associated Phospholipase A2, a Marker Linking Inflammation, Atherosclerosis, Vascular Events, Aging, and Cancer
by: Ying-Wen Su
Published: (2015-06-01) -
Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients.
by: Giuseppe Maiolino, et al.
Published: (2012-01-01) -
Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2
by: Robert S. Rosenson, et al.
Published: (2012-09-01) -
Lipoprotein-Associated Phospholipase A2 (Lp-PLA2): A Novel and Promising Biomarker for Cardiovascular Risks Assessment
by: Anping Cai, et al.
Published: (2013-01-01) -
Lipoprotein-associated phospholipase A2 levels as a predictor of cardiovascular risks in patients with COPD and obstructive sleep apnea
by: Eman A.E. Badr, et al.
Published: (2014-04-01)